News & Upcoming Events
Webinar: Accelerating Development of COVID-19 Vaccines Using InDevR's Novel VaxArray Coronavirus SeroAssay We Invite you to our free webinar on June 30th to learn about our new VaxArray Coronavirus SeroAssay ...
Read More
Read More
InDevR Delivers Commercial Multiplex Coronavirus SeroAssay Kit and Testing Services for Vaccine Development Boulder, CO – June 17, 2020– InDevR, Inc., a leader in novel analytical technologies that support the ...
Read More
Read More
InDevR Ships First Multiplexed COVID-19 Serology Test Kits for Clinical Validation Boulder, CO-9 April 2020– InDevR, Inc., a leader in progressive analytical technologies to support the development and production of ...
Read More
Read More
InDevR Raises $7 million in Series A Financing with Adjuvant Capital Boulder, CO, 10 September 2019 – InDevR, Inc., a biotechnology company focused on developing and commercializing novel analytical technologies ...
Read More
Read More
Clinical validation of the FluChip-8G Influenza A+B Assay for influenza type and subtype identification published in Journal of Clinical Virology Go to Abstract ...
Read More
Read More
Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay published in Journal of Virological Methods Go to Abstract ...
Read More
Read More
